MedTrace Logo

Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS

NCT06614595 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-09-27

No results posted yet for this study

Summary

Observational study to evaluate changes in quality of life (QoL) in patients diagnosed with low risk MDS who are red blood cell (abc) transfusion dependent.

Changes in QoL will be correlated with patient cardiorespiratory function. Cardiac biomarkers and plasma cytokines will also be evaluated.

Conditions

  • Low Risk Myelodysplastic Syndromes

Sponsors & Collaborators

  • Hospital Universitario Central de Asturias

    collaborator OTHER

  • Fundación para la Investigación Biosanitaria del Principado de Asturias

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-20
Primary Completion
2025-12-20
Completion
2025-12-21

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06614595 on ClinicalTrials.gov